Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Viracept
Active Ingredient(s): Nelfinavir mesylate 58.5mg/g equivalent 50 mg/g nelfinavir free base
Dosage Form: Powder for oral suspension
New Zealand Sponsor: Roche Products (New Zealand) Limited
Manufacturer(s): F Hoffmann-La Roche AG, Basel, Switzerland
Note: This consent is valid for 2 years from the 12th February 2002.
Product: Viracept
Active Ingredient(s): Nelfinavir mesylate 292.25mg equivalent 250 mg nelfinavir free base
Dosage Form: Tablet
New Zealand Sponsor: Roche Products (New Zealand) Limited
Manufacturer(s): F Hoffmann-La Roche AG, Basel, Switzerland
Mova Pharmaceutical Corporation, Villa Blanca Industrial Park, Caguas, Puerto Rico
Productos Roche S.A., Leganes (Madrid), Spain
Note: This consent is valid for 2 years from the 12th February 2002.
Dated this 24th day of October 2001.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).